These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 3315605)
1. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605 [TBL] [Abstract][Full Text] [Related]
2. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study. Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603 [TBL] [Abstract][Full Text] [Related]
3. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study. Monassier JP; Hanssen M Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540 [TBL] [Abstract][Full Text] [Related]
4. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study. Hoffmann JJ; Bonnier JJ; de Swart JB; Custers P; Vijgen M Drugs; 1987; 33 Suppl 3():242-6. PubMed ID: 3315602 [TBL] [Abstract][Full Text] [Related]
5. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC). Johnson ES; Cregeen RJ Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction. Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357 [TBL] [Abstract][Full Text] [Related]
18. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex. Kasper W; Meinertz T; Wollschläger H; Bonzel T; Wolff P; Drexler H; Hofmann T; Zeiher A; Just H Am J Cardiol; 1986 Sep; 58(6):418-21. PubMed ID: 3529908 [TBL] [Abstract][Full Text] [Related]
19. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States. Anderson JL Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584 [TBL] [Abstract][Full Text] [Related]
20. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study. Monnier P; Sigwart U; Vincent A; Bachmann F; Goy JJ; Schaller MD; Kaufmann U; Badan M; Grbic M; Perret C Drugs; 1987; 33 Suppl 3():175-8. PubMed ID: 3315587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]